MIMT1 and breast cancer: In the current study, to the best of our knowledge, for the first time, we have revealed that co-treatment of MDA-MB-231 breast cancer cells with MOXI and MIM1 resulted in a higher cytotoxic response of the analyzed cancer cells, pointing to the potential synergistic mode of action.